Welcome to our dedicated page for Arteris SEC filings (Ticker: AIP), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Arteris, Inc. (Nasdaq: AIP) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Arteris describes itself as a global leader in system IP used in semiconductors, and its filings offer formal detail on the financial and operational aspects behind that business.
Among the key documents are current reports on Form 8-K, which Arteris uses to furnish press releases announcing quarterly financial results and other material events. For example, the company has filed 8-Ks referencing press releases on results for quarters ended June 30 and September 30, including metrics such as revenue, licensing and royalty performance, operating loss, and Remaining Performance Obligations. These filings give investors structured insight into how Arteris’ licensing, support and maintenance, and variable royalty revenue streams are evolving.
Users can also review other periodic reports, such as Forms 10-Q and 10-K when available, to understand topics like segment performance, risk factors, and detailed financial statements that complement the high-level figures cited in press releases. For those interested in governance and ownership, SEC filings are the place where proxy statements and beneficial ownership reports would appear.
Stock Titan enhances this information by pairing real-time updates from EDGAR with AI-powered summaries that highlight the main points of lengthy filings. Instead of reading every line of a multi-page 10-K or 10-Q, users can rely on AI explanations to quickly identify revenue trends, key risks, and notable changes. The platform also surfaces insider transaction reports on Form 4 when filed, helping investors monitor trading activity by Arteris officers and directors.
By using this page, investors and researchers can efficiently navigate Arteris’ official SEC disclosures, from earnings-related 8-Ks to comprehensive annual and quarterly reports, supported by AI tools that make complex documents easier to interpret.
Arteris (NASDAQ:AIP) filed a Form 4 showing that VP & CFO Nicholas B. Hawkins sold a total of 11,276 common shares on 25-26 Jun 2025 under a pre-arranged Rule 10b5-1 plan.
- Sales volume: 5,638 shares at $9.50 and 5,638 at $9.75, raising roughly $108k.
- Ownership impact: holdings fell from 161,937 to 150,661 shares, a 7% reduction.
- Plan history: the 10b5-1 plan was adopted 20 May 2024; no derivative transactions were reported.
The transaction is modest in dollar terms but material in percentage for a C-suite executive, potentially influencing short-term sentiment.
Form 144 Notice of Proposed Sale filed by Arteris details insider trading activity by Nicholas Hawkins. The filing indicates a proposed sale of 11,276 shares of common stock with an aggregate market value of $101,709.52 through Morgan Stanley Smith Barney LLC, planned for execution on June 25, 2025 on NASDAQ.
Key transaction details:
- Original acquisition: 11,276 shares via stock options on December 19, 2019
- Current outstanding shares: 41,977,728
- Recent trading history: Hawkins executed multiple sales in past 3 months totaling 26,496 shares for approximately $193,623
- Most transactions were conducted under a 10b5-1 trading plan
This Form 144 represents a standard insider sale notification, with the seller affirming no knowledge of undisclosed material adverse information regarding Arteris's operations.